The Zn-dependent membrane-located protease YvjB has previously been shown to serve as a target receptor for LsbB, a class II leaderless lactococcal bacteriocin. Although yvjB is highly conserved in the genus Lactococcus, the bacteriocin appears to be active only against the subspecies L. lactis subsp. lactis. Comparative analysis of the YvjB proteins of a sensitive strain (YvjB MN ) and a resistant strain (YvjB MG ) showed that they differ from each other in 31 positions. In this study, we applied site-directed mutagenesis and performed directed binding studies to provide biochemical evidence that LsbB interacts with the third transmembrane helix of YvjB in susceptible cells. The site-directed mutagenesis of LsbB and YvjB proteins showed that certain amino acids and the length of LsbB are responsible for the bacteriocin activity, most probably through adequate interaction of these two proteins; the essential amino acids in LsbB responsible for the activity are tryptophan (
Bacteriocins are small, ribosomally synthesized, cationic, and hydrophobic peptides produced by various bacteria, and they are often found to be active against bacteria closely related to the producers. However, some also have broader inhibitory spectra, including pathogens and problematic bacteria. Producer organisms are immune to their own bacteriocin(s), a property that is mediated by specific immunity proteins (1).Bacteriocins from Gram-positive bacteria are generally classified into two main groups: the class I lantibiotics, containing posttranslationally modified peptides with ring-forming lanthionine or methyllanthionine residues, and class II, composed of nonmodified or minimally modified peptide bacteriocins (1-3). Class II bacteriocins are further subdivided into pediocin-like bacteriocins (class IIa), two-peptide bacteriocins (class IIb), circular bacteriocins (class IIc), and nonpediocin one-peptide bacteriocins (class IId) (2).Bacteriocins have been much studied from a fundamental and scientific perspective and also for their potential applications as food preservatives, and in veterinary and human medicine as alternatives to antibiotics or as synergists (1, 4).Bacteriocins have a number of positive attributes that have made them especially attractive for various applications (5). Some of them exhibit a broad spectrum of activity, inhibiting microorganisms belonging to different genera and species, including many bacterial pathogens that cause human, animal, or plant infections (6). For clinical applications, bacteriocins have been presented as a viable alternative to antibiotics due to the high specificity of certain bacteriocins against clinical pathogens, including multidrug-resistant (MDR) strains (4). Therefore, these substances have various potential applications in the food industry and medicine, either alone or in combination with other chemicals or methods (7).The multiplicity and diversity of bacteriocins and the resultant effects of their interactions with targeted bacteria on microbial ecology have been thoro...